Covista (CVSA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
14 Oct, 2026Executive summary
Supplement dated Oct. 14, 2026, clarifies voting standards for the Nov. 11, 2026 annual meeting; proposals remain unchanged.
Shareholders who already voted by Internet, telephone, or mail need not act unless they want to change their vote.
Voting matters and shareholder proposals
Abstentions, withheld votes, and broker non-votes count toward quorum but not votes on director elections, advisory executive compensation, or the 2026 equity incentive plan.
Brokers may vote uninstructed shares only on auditor ratification; broker non-votes are present for quorum and may be voted on that proposal.
Required approval standard clarified as a majority of shares represented and entitled to vote on each proposal.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Covista
- FY26 outperformance closes one strategy; a new plan targets growth through FY29.CVSA
Proxy filing - Board backs all four voting matters at the November 11, 2026 virtual meeting.CVSA
Proxy filing - Sustained growth, campus expansion, and strategic partnerships drive a leading healthcare education platform.CVSA
2026 Jefferies Healthcare Services and Technology Conference - Double-digit EPS growth, record enrollments, and strong FY27 outlook delivered.CVSA
Q4 2026 - Record enrollment and revenue growth, raised guidance, and strong capital allocation.CVSA
Q3 2026 - AI-driven growth and operational excellence support double-digit earnings and enrollment targets.CVSA
Investor Day 2026 - Enrollment and revenue growth drive strong earnings and positive 2026 outlook.CVSA
Q1 2026 - Double-digit enrollment and revenue growth drive record results and strong FY25 outlook.CVSA
Q4 2024 - Record enrollment and margin gains highlight strong growth in healthcare education.CVSA
Baird 2024 Global Consumer, Technology & Services Conference